David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$546M |
| 2 |
Amazon
AMZN
|
+$515M |
| 3 |
Tesla
TSLA
|
+$389M |
| 4 |
Netflix
NFLX
|
+$322M |
| 5 |
Adobe
ADBE
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$836M |
| 2 |
CELG
Celgene Corp
CELG
|
+$460M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
ConocoPhillips
COP
|
+$311M |
| 5 |
Biogen
BIIB
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.8% |
| 2 | Consumer Discretionary | 11.76% |
| 3 | Healthcare | 10.16% |
| 4 | Financials | 7.89% |
| 5 | Industrials | 6.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
PUT
AB InBev
BUD
$155B
| $11.7M | 0.01% |
142,500
-74,700
| -34% | -$6.22M |
|
1077
CALL
Bausch Health
BHC
$2.52B
| $11.7M | 0.01% |
390,000
+70,000
| +22% | +$1.82M |
|
|
COWN
1078
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $11.6M | 0.01% |
738,831
-126,144
| -15% | -$1.89M |
|
|
ICPT
1079
CALL
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $11.6M | 0.01% |
93,700
+11,100
| +13% | +$994K |
|
1080
PUT
Fair Isaac
FICO
$24.6B
| $11.6M | 0.01% |
30,900
-35,800
| -54% | -$12M |
|
1081
PUT
Boston Beer
SAM
$1.95B
| $11.6M | 0.01% |
30,600
-1,100
| -3% | -$414K |
|
1082
Dr. Reddy's Laboratories
RDY
$10.3B
| $11.5M | 0.01% |
1,419,455
+280,785
| +25% | +$2.22M |
|
1083
Portland General Electric
POR
$5.86B
| $11.5M | 0.01% |
206,233
-111,728
| -35% | -$6.24M |
|
|
XENT
1084
DELISTED
Intersect ENT, Inc
XENT
| $11.5M | 0.01% |
460,132
+221,917
| +93% | +$4.5M |
|
1085
Cerus
CERS
$548M
| $11.5M | 0.01% |
2,714,158
+727,056
| +37% | +$3.13M |
|
1086
COPT Defense Properties
CDP
$4.26B
| $11.4M | 0.01% |
389,636
+185,953
| +91% | +$5.43M |
|
1087
Selective Insurance
SIGI
$5.47B
| $11.4M | 0.01% |
175,510
+161,367
| +1,141% | +$11.2M |
|
|
SGI
1088
Somnigroup International
SGI
$13.5B
| $11.4M | 0.01% |
524,744
-529,748
| -50% | -$11.1M |
|
1089
Mettler-Toledo International
MTD
$28.1B
| $11.4M | 0.01% |
14,390
+10,073
| +233% | +$7.27M |
|
|
PPLI
1090
CALL
People Inc
PPLI
$2.94B
| $11.4M | 0.01% |
255,710
| – | – |
|
|
WBA
1091
CALL
DELISTED
Walgreens Boots Alliance
WBA
| $11.3M | 0.01% |
192,300
+77,900
| +68% | +$4.49M |
|
1092
CALL
Genuine Parts
GPC
$19B
| $11.3M | 0.01% |
106,600
+45,600
| +75% | +$4.69M |
|
1093
CALL
Allegiant Air
ALGT
$2.25B
| $11.3M | 0.01% |
64,800
+24,800
| +62% | +$4.11M |
|
|
BBBY
1094
DELISTED
Bed Bath & Beyond Inc
BBBY
| $11.3M | 0.01% |
+650,613
| New | +$9.11M |
|
1095
NetEase
NTES
$82.5B
| $11.2M | 0.01% |
183,135
-1,052,960
| -85% | -$61.7M |
|
1096
Kemper
KMPR
$1.64B
| $11.2M | 0.01% |
144,559
+63,712
| +79% | +$4.75M |
|
1097
PUT
Ball Corp
BALL
$17B
| $11.1M | 0.01% |
172,400
+104,800
| +155% | +$7.1M |
|
1098
PUT
Stellantis
STLA
$19.8B
| $11.1M | 0.01% |
758,000
+80,000
| +12% | +$1.16M |
|
|
DFS
1099
CALL
DELISTED
Discover Financial Services
DFS
| $11.1M | 0.01% |
131,100
-13,100
| -9% | -$1.08M |
|
1100
Manhattan Associates
MANH
$12.4B
| $11.1M | 0.01% |
138,970
-135,727
| -49% | -$10.8M |
|
Similar funds
David Shaw's Q4 2019 Portfolio in Review
As of Q4 2019, David Shaw held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
David Shaw's Q4 2019 filing shows 572 new, 1,477 increased, 1,498 reduced and 412 closed positions. Its largest new stake was Tesla: 17,953,230 shares worth $501M. The largest sale was Alibaba, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
- David Shaw added most to Emerson Electric in Q4 2019, an estimated $546M increase.
- David Shaw's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
- David Shaw fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
- David Shaw's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
- David Shaw opened 572 new positions and closed 412 in Q4 2019.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $87.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.